Rosenberg Graeme M, Knowlton Lisa, Rajasingh Charlotte, Weng Yingjie, Maggio Paul M, Spain David A, Staudenmayer Kristan L
Department of Surgery, Section of Acute Care Surgery, Stanford University, Stanford, California.
Stanford-Surgery Policy Improvement Research and Education Center, Department of Surgery, Stanford University, Stanford, California.
JAMA Surg. 2017 Dec 1;152(12):1119-1125. doi: 10.1001/jamasurg.2017.2643.
Options for managing splenic injuries have evolved with a focus on nonoperative management. Long-term outcomes, such as readmissions and delayed splenectomy rate, are not well understood.
To describe the natural history of isolated splenic injuries in the United States and determine whether patterns of readmission were influenced by management strategy.
DESIGN, SETTING, AND PARTICIPANTS: The Healthcare Cost and Utilization Project's Nationwide Readmission Database is an all-payer, all-ages, longitudinal administrative database that provides data on more than 35 million weighted US discharges yearly. The database was used to identify patients with isolated splenic injuries and the procedures that they received. Adult patients with isolated splenic injuries admitted from January 1 through June 30, 2013, and from January 1 through June 30, 2014, were included. Those who died during the index hospitalization or who had an additional nonsplenic injury with an Abbreviated Injury Score of 2 or greater were excluded. Univariate and mixed-effects logistic regression analysis controlling for center effect were used. Weighted numbers are reported.
Initial management strategy at the time of index hospitalization, including nonprocedural management, angioembolization, and splenectomy.
All-cause 6-month readmission rate. Secondary outcome was delayed splenectomy rate.
A weighted sample of 3792 patients (2146 men [56.6%] and 1646 women [43.4%]; mean [SE] age, 48.5 [0.7] years) with 5155 admission events was included. During the index hospitalization, 825 (21.8%) underwent splenectomy, 293 (7.7%) underwent angioembolization, and 2673 (70.5%) had no procedure. The overall readmission rate was 21.1% (799 patients). Readmission rates did not differ based on initial management strategy (195 patients undergoing splenectomy [23.6%], 70 undergoing angioembolism [23.9%], and 534 undergoing no procedure [20%]; P = .33). Splenectomy was performed in 36 of 799 readmitted patients (4.5%) who did not have a splenectomy at their index hospitalization, leading to an overall delayed splenectomy rate of 1.2% (36 of 2967 patients). In mixed-effects logistic regression analysis controlling for patient, injury, clinical, and hospital characteristics, the choice of splenectomy (odds ratio, 0.93; 95% CI, 0.66-1.31) vs angioembolization (odds ratio, 1.19; 95% CI, 0.72-1.97) as initial management strategy was not associated with readmission.
This national evaluation of the natural history of isolated splenic injuries from index admission through 6 months found that approximately 1 in 5 patients are readmitted within 6 months of discharge after an isolated splenic injury. However, the chance of readmission for splenectomy after initial nonoperative management was 1.2%. This finding suggests that the current management strategies used for isolated splenic injuries in the United States are well matched to patient need.
脾损伤的管理方式不断演变,目前侧重于非手术治疗。但对于再入院率和延迟脾切除率等长期结果,我们了解得还不够充分。
描述美国孤立性脾损伤的自然病程,并确定管理策略是否会影响再入院模式。
设计、地点和参与者:医疗成本和利用项目的全国再入院数据库是一个全付费、全年龄段的纵向管理数据库,每年提供超过3500万次加权美国出院数据。该数据库用于识别患有孤立性脾损伤的患者及其接受的治疗程序。纳入了2013年1月1日至6月30日以及2014年1月1日至6月30日期间入院的成年孤立性脾损伤患者。排除了在首次住院期间死亡或有其他非脾损伤且简明损伤评分≥2分的患者。采用单因素和混合效应逻辑回归分析,并控制中心效应。报告加权数字。
首次住院时的初始管理策略,包括非手术治疗、血管栓塞和脾切除术。
全因6个月再入院率。次要结局是延迟脾切除率。
纳入了一个加权样本,共3792例患者(2146例男性[56.6%]和1646例女性[43.4%];平均[标准差]年龄为48.5[0.7]岁),有5155次入院事件。在首次住院期间,825例(21.8%)接受了脾切除术,293例(7.7%)接受了血管栓塞,2673例(70.5%)未接受任何治疗。总体再入院率为21.1%(799例患者)。再入院率在初始管理策略方面没有差异(195例接受脾切除术的患者[23.6%],70例接受血管栓塞的患者[23.9%],534例未接受任何治疗的患者[20%];P = 0.33)。在799例再入院患者中,36例(4.5%)在首次住院时未接受脾切除术,此次进行了脾切除术,导致总体延迟脾切除率为1.2%(2967例患者中的36例)。在控制患者、损伤、临床和医院特征的混合效应逻辑回归分析中,作为初始管理策略,选择脾切除术(比值比,0.93;95%置信区间,0.66 - 1.31)与血管栓塞术(比值比,1.19;95%置信区间,0.72 - 1.97)与再入院无关。
这项对孤立性脾损伤从首次入院到6个月自然病程的全国性评估发现,约五分之一的患者在孤立性脾损伤出院后6个月内再次入院。然而,初始非手术治疗后因脾切除而再入院的几率为1.2%。这一发现表明,美国目前用于孤立性脾损伤的管理策略与患者需求高度匹配。